DOI: 10.1192/j.eurpsy.2026.11578 ISSN: 0924-9338

Beyond Symptom Control: Surgical Treatment of Benign Prostatic Hyperplasia and Reduced Risks of Depression, Anxiety, and Dementia

S.-K. Kao, W.-Y. Cheng, Y.-T. Yu, W.-H. Tseng

Introduction

Benign prostatic hyperplasia (BPH) is a common urological condition in aging men, often causing lower urinary tract symptoms (LUTS). LUTS are linked not only to impaired quality of life but also to psychiatric disorders, sleep disturbances, and cognitive decline. While surgical treatment is widely used to relieve bladder outlet obstruction, its long-term impact on psychiatric and cognitive outcomes remains unclear.

Objectives

To evaluate whether surgical treatment for BPH is associated with reduced risks of psychiatric disorders, sleep disturbances, cognitive decline, and persistent LUTS.

Methods

A retrospective cohort study was conducted using the TriNetX Global Collaborative Network (155 healthcare organizations). Male patients aged ≥18 years with BPH (2015–2024) were included. Patients with baseline psychiatric disorders were excluded. The study population was divided into surgical (n = 20,328) and non-surgical (n = 1,659,904) cohorts. After 1:1 propensity score matching, 20,323 patients remained in each group. Outcomes within three years included depression, anxiety, insomnia, dementia, delirium, and LUTS. Hazard ratios (HR) and p-values were calculated. Subgroup analyses were performed by age and BPH medication use.

Results

Surgical patients had lower risks of persistent LUTS (HR 0.917, p < 0.001), depression (HR 0.616, p < 0.001), anxiety (HR 0.551, p < 0.001), insomnia (HR 0.645, p < 0.001), dementia (HR 0.705, p = 0.013), and delirium (HR 0.694, p = 0.007). Benefits were more pronounced in men aged 18–70 for LUTS, depression, anxiety, and insomnia, whereas men >70 mainly benefited for depression, anxiety, and dementia. Protective effects were stronger in patients not taking medications.

Table 1.

Risk of Psychiatric Disorders and LUTS in BPH Patients Undergoing Surgery versus Non-Surgical Controls (BPH = Benign Prostatic Hyperplasia; LUTS = Lower Urinary Tract Symptoms; HR = Hazard Ratio; CI = Confidence Interval; * p < 0.05; *** p < 0.001)

Table 1. Long description.

Outcome
Surgery (N=20,323)
non-Surgery (N= 20,323) Hazard ratio (95% CI) p value
LUTS
3004
3706 0.917 (0.874, 0.963) < 0.001***
Depression
106 196 0.616 (0.486, 0.780) < 0.001***
Anxiety
144 297 0.551 (0.451, 0.672) < 0.001***
Insomnia
90 159 0.645 (0.498, 0.835) < 0.001***
Dementia
81 131 0.705 (0.535, 0.930) 0.013*
Delirium
86 141 0.694 (0.530, 0.907) 0.007*

Image 1. Kaplan–Meier Curve of Psychiatric Disorder Risk in BPH Patients Undergoing Surgery versus Non-Surgical Controls (BPH = Benign Prostatic Hyperplasia)

Image 2 & 3. Subgroup Analysis Forest Plot of Outcomes After Surgery versus Controls (BPH = Benign Prostatic Hyperplasia; LUTS = Lower Urinary Tract Symptoms; HR = Hazard Ratio; CI = Confidence Interval)

Image 1:

Image 1: Long description.

Image 2:

Image 2: Long description.

Image 3:

Image 3: Long description.

Conclusions

Surgical treatment for BPH is associated with reduced risks of psychiatric disorders. Beyond relieving urinary obstruction, surgery may confer broader mental health and cognitive benefits.

Disclosure of Interest

None Declared

More from our Archive